You are here: Industry Insights > Mergers and Acquisitions

News List

Evolving World of Pharma: Uniting pharma for value and innovation Sarah Harding
June 27, 2019
Pharma probably sees more M&A activity than any other industry, both in terms of the number of deals and the amount of money spent.
Pfizer, Merck, J&J well-positioned for M&A and Biogen and BioMarin are prime targets: report fiercepharma
February 22, 2019
This year is already shaping up to be a big one for biopharma mergers and acquisitions, with Bristol-Myers Squibb’s planned $74 billion buyout of Celgene well underway.
Long-awaited M&A boom will hit biopharma in 2019 despite persistent worries, prognosticators predict fiercepharma
December 20, 2018
When Congress passed a business-friendly tax package last year, pharma prognosticators predicted 2018 would be the year that mergers and acquisitions in the sector would finally gain steam. They were wrong.
Ophthotech adds to pipeline again as climb back continuesipeline again as climb back continues fiercebiotech
November 02, 2018
Ophthotech has signed two deals to bulk up its drug and gene therapy pipeline, following the demise of its lead wet age-related macular degeneration (AMD) candidate last year.
Allergan defuses Botox threat with $195M Bonti buy fiercebiotech
September 18, 2018
Bonti’s EB-001 works similarly to Botox, but it acts more quickly and its effects don’t last as long.
Boehringer buys oncolytic virus startup ViraTherapeutics fiercebiotech
September 14, 2018
The potential for oncolytic viruses to broaden the effectiveness of checkpoint inhibitors has returned the modality to the spotlight.
UL absorbs U.K.-based medtech human factors firm fiercebiotech
September 11, 2018
Medical Device Usability and UL’s human factors staff will become a single team, based at locations throughout the world.
10x Genomics acquires epigenetic startup Epinomics in first M&A fiercebiotech
September 03, 2018
Epinomics was founded by the developers of ATAC-seq technology, for profiling the compounds and proteins that attach to DNA and turn specific genes on or off. (kirstypargeter/iStock/Getty Images Plus)
Top 3 Takeover Targets for Pfizer biospace
January 24, 2018
The year is already off to a good start with mergers and acquisitions in the biopharma industry. Celgene Corporation acquired Juno Therapeutics for $9 billion yesterday, and Sanofi bought Biogen spinoff Bioverativ for $11.6 billion.
3 Biopharmas Worth Watching in 2018 biospace
January 16, 2018
Because of changes to the tax code, many investors are hoping M&A activity will pick up. Others are just hoping they can get a handle on rising stocks. Here are three biopharma stocks worth keeping an eye on.

Previous page 1 2 Next page